Specificity of Lipoprotein-Associated Phospholipase A(2) Towards Oxidized Phosphatidylserines: LC-ESI-MS Characterization of Products and Computer Modeling of Interactions

Por Tyurin, Vladimir A., Yanamala, Naveena, Tyurina, Yulia Y., Klein-Seetharaman, Judith, Macphee, Colin H., Kagan, Valerian E.
Publicado em 2012

Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A(2) Activity: A Randomized, Controlled Trial

Por Johnson, Joel L., Shi, Yi, Snipes, Rose, Janmohamed, Salim, Rolfe, Timothy E., Davis, Bill, Postle, Anthony, Macphee, Colin H.
Publicado em 2014

Platelet Aggregation Unchanged by Lipoprotein-Associated Phospholipase A(2) Inhibition: Results from an In Vitro Study and Two Randomized Phase I Trials

Por Shaddinger, Bonnie C., Xu, Yanmei, Roger, James H., Macphee, Colin H., Handel, Malcolm, Baidoo, Charlotte A., Magee, Mindy, Lepore, John J., Sprecher, Dennis L.
Publicado em 2014

Atherosclerotic Plaque Inflammation Varies Between Vascular Sites and Correlates With Response to Inhibition of Lipoprotein‐Associated Phospholipase A(2)

Por Fenning, Robert S., Burgert, Mark E., Hamamdzic, Damir, Peyster, Eliot G., Mohler, Emile R., Kangovi, Shreya, Jucker, Beat M., Lenhard, Stephen C., Macphee, Colin H., Wilensky, Robert L.
Publicado no J Am Heart Assoc (2015)

Inhibition of lipoprotein-associated phospholipase A(2) reduces complex coronary atherosclerotic plaque development

Por Wilensky, Robert L, Shi, Yi, Mohler, Emile R, Hamamdzic, Damir, Burgert, Mark E, Li, Jun, Postle, Anthony, Fenning, Robert S, Bollinger, James G, Hoffman, Bryan E, Pelchovitz, Daniel J, Yang, Jisheng, Mirabile, Rosanna C, Webb, Christine L, Zhang, LeFeng, Zhang, Ping, Gelb, Michael H, Walker, Max C, Zalewski, Andrew, Macphee, Colin H
Publicado em 2008